Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Angiodynamics (ANGO) Restructuring Costs (2016 - 2025)

Historic Restructuring Costs for Angiodynamics (ANGO) over the last 14 years, with Q4 2025 value amounting to $3.6 million.

  • Angiodynamics' Restructuring Costs fell 3805.39% to $3.6 million in Q4 2025 from the same period last year, while for Nov 2025 it was $11.8 million, marking a year-over-year decrease of 7806.93%. This contributed to the annual value of $15.6 million for FY2025, which is 7062.92% down from last year.
  • Angiodynamics' Restructuring Costs amounted to $3.6 million in Q4 2025, which was down 3805.39% from $2.8 million recorded in Q3 2025.
  • Angiodynamics' 5-year Restructuring Costs high stood at $35.4 million for Q1 2024, and its period low was $610000.0 during Q1 2021.
  • Over the past 5 years, Angiodynamics' median Restructuring Costs value was $3.3 million (recorded in 2023), while the average stood at $5.9 million.
  • Per our database at Business Quant, Angiodynamics' Restructuring Costs surged by 102401.83% in 2021 and then crashed by 9070.89% in 2025.
  • Quarter analysis of 5 years shows Angiodynamics' Restructuring Costs stood at $2.3 million in 2021, then soared by 35.77% to $3.1 million in 2022, then surged by 102.29% to $6.2 million in 2023, then decreased by 5.17% to $5.9 million in 2024, then plummeted by 38.05% to $3.6 million in 2025.
  • Its Restructuring Costs was $3.6 million in Q4 2025, compared to $2.8 million in Q3 2025 and $2.2 million in Q2 2025.